SCHEMBL20122759

SCHEMBL20122759

Cc1cc(-c2cc(Cl)cc3c4ccnc(C)c4n(CC4CC4)c23)cnc1C#N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 2/20 0.38
MAOA P21397 1/20 0.38
CRHR1 P34998 1/20 0.34
PADI4 Q9UM07 1/20 0.34
HDAC1 Q13547 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
KDM1A O60341 2/20 0.33
GRM2 Q14416 1/20 0.33
GRIN2B Q13224 2/20 0.32
GRIN1 Q05586 1/20 0.32
ACHE P22303 2/20 0.32
DYRK2 Q92630 2/20 0.32
HASPIN Q8TF76 1/20 0.32
DYRK3 O43781 1/20 0.32
CLK1 P49759 1/20 0.32
CLK2 P49760 1/20 0.32
CLK3 P49761 1/20 0.32
GSK3B P49841 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32
DYRK4 Q9NR20 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122939 0.87 PIK3CA (0.38) DYRK1AMAOACRHR1HDAC1HDAC6
SCHEMBL29756567 0.85 DYRK1A (0.35) DYRK1AMAOACRHR1HDAC1HDAC6
SCHEMBL29756577 0.84 BCL6 (0.37) DYRK1AMAOACRHR1HDAC1HDAC6
SCHEMBL30664235 0.83 HDAC1 (0.35) DYRK1AMAOACRHR1HDAC1HDAC6
SCHEMBL20122880 0.83 HDAC1 (0.35) DYRK1AMAOACRHR1HDAC1HDAC6
SCHEMBL20122937 0.82 BRD4 (0.37) DYRK1AMAOACRHR1HDAC1HDAC6
SCHEMBL30664292 0.82 BRD4 (0.37) DYRK1AMAOACRHR1HDAC1HDAC6
SCHEMBL22474564 0.80 CRHR1 (0.37) DYRK1AMAOACRHR1HDAC1HDAC6
SCHEMBL30664216 0.80 CRHR1 (0.37) DYRK1AMAOACRHR1HDAC1HDAC6
SCHEMBL20122960 0.79 DYRK1A (0.45) DYRK1AMAOAHDAC1HDAC6GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827633-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders SANOFI (FR) 2023-11-28 US disclosed
US-11827633-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders SANOFI (FR) 2023-11-28 US disclosed
CN-110382496-B Substituted pyrido [3,4-b ] indoles for the treatment of cartilage disorders 赛诺菲 2022-08-09 CN disclosed
US-11130755-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders SANOFI (FR) 2021-09-28 US disclosed
EP-3792262-A1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS SANOFI (FR) 2021-03-17 EP disclosed
EP-3535263-B1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS SANOFI SA (FR) 2020-09-30 EP disclosed
EP-3318563-A1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS SANOFI (FR) 2018-05-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11827633-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders COL2A1, IDO1, COL1A1 DYRK1A 493/4885MAOA 245/4885CRHR1 908/4885
US-11130755-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders COL2A1, IDO1, COL1A1 DYRK1A 493/4885MAOA 245/4885CRHR1 908/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.